Citigroup’s Dimension Therapeutics, Inc DMTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DMTX
O
NLVP
BBA
HIM
AG
RSCM
PAMP
Citigroup's DMTX Position: Q3 2017 in Review
Citigroup sold out of Dimension Therapeutics, Inc (DMTX) in Q3 2017, closing a stake of 1 share.
Citigroup first reported a position in DMTX in Q4 2015 and held it in 7 quarters. The position peaked at $54K in Q4 2016. 34 funds tracked by Wall St. Rank hold DMTX as of Q3 2017.
- Citigroup reported no remaining Dimension Therapeutics, Inc position as of Q3 2017 after selling out during the quarter.
- Citigroup sold 1 Dimension Therapeutics, Inc share in Q3 2017.
- Citigroup first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 7 quarters.
- Citigroup's Dimension Therapeutics, Inc position peaked at $54K in Q4 2016.
- 34 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q3 2017.
Based on Citigroup's 13F filing for Q3 2017, filed 13 Nov 2017.